Research Analysts Set Expectations for APLS Q2 Earnings
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) – Analysts at William Blair lifted their Q2 2026 earnings per share (EPS) estimates for Apellis Pharmaceuticals in a research note issued to investors on Tuesday, April 1st. William Blair analyst L. Hanbury-Brown now expects that the company will earn $0.20 per share for the quarter, up from […]
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) – Analysts at William Blair lifted their Q2 2026 earnings per share (EPS) estimates for Apellis Pharmaceuticals in a research note issued to investors on Tuesday, April 1st. William Blair analyst L. Hanbury-Brown now expects that the company will earn $0.20 per share for the quarter, up from […]
